Literature DB >> 7598493

Possible role of endothelin in endothelial regulation of vascular tone.

T Masaki1.   

Abstract

In vascular beds, a potent vasoconstrictor of endothelin-1 (ET-1) is produced by endothelial cells and released preferentially to the basal side of endothelial cells. It acts on endothelial cells and on the underlying smooth muscle cells, as a modulator of vascular tone, in an autocrine and paracine manner. ET-1 induces release of relaxing factors (nitric oxide and prostacycline) from endothelial cells. Whether relaxation or constriction is predominantly elicited by endogenous ET-1 may depend on the concentration of ET-1 in vascular beds, the density and mode of distribution of ET receptor subtypes on the endothelial and smooth muscle cells, the turnover of the receptors, and the existing conditions of each vascular beds. When ET-1 is overproduced by endothelial cells at pathological conditions, endogenous ET-1 acts as a vasoconstrictor. However, ET-1 may act as a vasodilator at physiologically low concentrations, depending on the existing condition.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7598493     DOI: 10.1146/annurev.pa.35.040195.001315

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


  28 in total

Review 1.  Structural basis of the function of endothelin receptor.

Authors:  T Masaki; H Ninomiya; A Sakamoto; Y Okamoto
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

Review 2.  DNA antisense strategies in the study of receptors for vasoactive peptides, and of growth and wound-healing factors.

Authors:  P D'Orléans-Juste; M G Sirois; E R Edelman; D Regoli; L H Pheng; G Bkaily; C J Lindsey
Journal:  Mol Cell Biochem       Date:  1997-07       Impact factor: 3.396

Review 3.  Age-related endothelial dysfunction : potential implications for pharmacotherapy.

Authors:  Rachel L Matz; Ramaroson Andriantsitohaina
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

4.  Endothelial cell function in patients with hereditary angioedema: elevated soluble E-selectin level during inter-attack periods.

Authors:  Judit Czúcz; Gyula Schaffer; Dorottya Csuka; Szilvia Walentin; Jan Kunde; Zoltán Prohászka; Henriette Farkas; László Cervenak
Journal:  J Clin Immunol       Date:  2011-10-19       Impact factor: 8.317

5.  Involvement of Endothelin Receptors in Peripheral Sensory Neuropathy Induced by Oxaliplatin in Mice.

Authors:  Renata Bessa Pontes; Mario Roberto Pontes Lisboa; Anamaria Falcão Pereira; Juliana Arcanjo Lino; Francisco Fábio Bezerra de Oliveira; Aline Kelly Viana de Mesquita; Bruno Wesley de Freitas Alves; Roberto César Pereira Lima-Júnior; Mariana Lima Vale
Journal:  Neurotox Res       Date:  2019-06-21       Impact factor: 3.911

6.  Role of statins in cerebral vasospasm.

Authors:  T Sugawara; R Ayer; J H Zhang
Journal:  Acta Neurochir Suppl       Date:  2008

Review 7.  Vascular plasticity in cerebrovascular disorders.

Authors:  Lars I H Edvinsson; Gro Klitgaard Povlsen
Journal:  J Cereb Blood Flow Metab       Date:  2011-05-11       Impact factor: 6.200

8.  Dual endothelin receptor antagonism prevents remodeling of resistance arteries in diabetes.

Authors:  Kamakshi Sachidanandam; Vera Portik-Dobos; Aisha I Kelly-Cobbs; Adviye Ergul
Journal:  Can J Physiol Pharmacol       Date:  2010-06       Impact factor: 2.273

9.  Modulation of human colon tumor-stromal interactions by the endothelin system.

Authors:  G Egidy; L Juillerat-Jeanneret; J F Jeannin; P Korth; F T Bosman; F Pinet
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

10.  Generation and characterization of rendomab-B1, a monoclonal antibody displaying potent and specific antagonism of the human endothelin B receptor.

Authors:  Bertrand Allard; Anne Wijkhuisen; Aurélie Borrull; Frédérique Deshayes; Fabienne Priam; Patricia Lamourette; Frédéric Ducancel; Didier Boquet; Jean-Yves Couraud
Journal:  MAbs       Date:  2012-12-05       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.